Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
Key facts
- Who runs it
- Udayana University
- Where
- Indonesia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 72 people, planned
- Started
- 13 Dec 2024
- Ended
- 13 Feb 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
- Nebulized 0.9% Normal Saline
- Record updated
- 22 January 2025
Who can take part
- Age
- 2 years to 6 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Pediatric patients aged 2 to 6 years old
- Planned general anesthesia using inhalation sevoflurane with endotracheal tube techniques
- Parents agree to participate in the study
Who cannot take part
- Emergency surgery
- History of upper respiratory infection within 2 weeks before the procedure
- Surgery duration estimation exceeding 180 minutes
- history or diagnosed with mental or cognitive disorders
- History of allergy to dexmedetomidine
- Pediatric patients with > ASA II
- Difficult airway management
- Congenital abnormalities of vital organs
- Malnutrition
- Parents refuse to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia.
Read full original descriptionShow less
Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.
The 2 groups in the trial
- Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool ChildrenExisting treatment, for comparison
Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.
- Nebulized Normal Saline 0.9% for Post-Anesthesia Delirium in Preschool ChildrenPlacebo, for comparison
Nebulization with normal saline 0.9% 3ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.
Treatment: Nebulized 0.9% Normal Saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Nebulized Dexmedetomidine to Reduce Post-Anesthesia Delirium of Sevoflurane in Preschool Children Undergoing Elective Surgery
- Record updated
- 22 January 2025